LRP2 and mesothelioma: As expected, LRP2 was highly expressed in tumors that arise from absorptive epithelia, such as clear cell renal cell carcinoma, papillary renal cell carcinoma, mesothelioma, invasive breast carcinoma, and papillary thyroid cancer.